CD4 and breast cancer: Compared to mice with single deficiencies in T cell PARP1 or PARP2, mice with PARP1/2 double deficiencies have faster proliferating breast cancer cells and reduced CD4+ and CD8+ T cell infiltration in tumor tissues (128).